Connective tissue growth factor hammerhead ribozyme attenuates human hepatic stellate cell function

Area of Science:

• Molecular biology
• Cell biology
• Biochemistry

Background:

• Connective tissue growth factor (CCN2) plays a role in hepatic stellate cell (HSC) activation and fibrosis.
• Transforming growth factor-beta1 (TGF-β1) is a key mediator in liver fibrosis, stimulating HSCs.

Purpose of the Study:

• To investigate the effect of a hammerhead ribozyme targeting CCN2 on human HSC function.
• To determine CCN2's role in TGF-β1-induced collagen production and cell cycle progression.

Main Methods:

• Constructed a hammerhead ribozyme targeting CCN2 (pTriCCN2-Rz) and transfected it into LX-2 HSCs.
• Stimulated cells with TGF-β1 and analyzed CCN2 and collagen I mRNA and protein levels.
• Assessed cell-cycle progression using flow cytometry.

Main Results:

• pTriCCN2-Rz transfection decreased basal and TGF-β1-induced CCN2 and collagen I expression in LX-2 cells.
• Inhibition of CCN2 partially blocked TGF-β1-induced collagen production.
• Reduced CCN2 levels led to decreased cell transition into S phase.

Conclusions:

• Endogenous CCN2 mediates basal and TGF-β1-induced collagen I production in human HSCs.
• CCN2 regulates human HSC entry into the S phase of the cell cycle.